cilostazol has been researched along with Carcinoma, Hepatocellular in 1 studies
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol treatment enhanced the uptake of lipidated apoE3, and this effect was abolished when LRP1 was silenced by siRNA knockdown." | 1.40 | The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression. ( Cha, BS; Jeon, BH; Kang, ES; Kim, HJ; Kim, HM; Lee, B; Lee, HC; Moon, JH; Yun, MR, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HJ | 1 |
| Moon, JH | 1 |
| Kim, HM | 1 |
| Yun, MR | 1 |
| Jeon, BH | 1 |
| Lee, B | 1 |
| Kang, ES | 1 |
| Lee, HC | 1 |
| Cha, BS | 1 |
1 other study available for cilostazol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.
Topics: Animals; Apolipoprotein E3; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cilostaz | 2014 |